Type of Study:
A Randomized, Double- Blind, Placebo-Controlled Trial for weight maintenance or weight loss for participants who have obesity or are overweight with weight-related diseases.
Approximately 79 weeks (22 visits)
over 18 years, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
This is a study of tirzepatide in participants with type 2 diabetes who have obesity or are overweight. The main purpose is to learn more about how tirzepatide affects body weight.